Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.57 USD | +0.72% | +0.23% | -14.11% |
04-03 | DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) added to S&P 1000 | CI |
04-03 | DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) added to S&P 400 Health Care | CI |
Strengths
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company is in debt and has limited leeway for investment
- With a 2024 P/E ratio at 23.28 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.11% | 6.35B | B- | ||
-2.31% | 187B | C+ | ||
-3.20% | 106B | C | ||
-5.04% | 66.9B | A | ||
+0.20% | 49.45B | B- | ||
+17.29% | 48B | B- | ||
+4.06% | 40.84B | B+ | ||
+2.07% | 26.48B | B | ||
+2.36% | 26.25B | A- | ||
+12.96% | 24.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- XRAY Stock
- Ratings DENTSPLY SIRONA Inc.